Atnaujinkite slapukų nuostatas

Recent Advances and Future Directions in Bone Marrow Transplantation: Proceedings of a Symposium Held in Conjunction with the 16th Annual Meeting of the International Society for Experimental Hematology, August 2328, 1987, Tokyo, Japan Softcover reprint of the original 1st ed. 1988 [Minkštas viršelis]

Edited by , Edited by , Edited by
  • Formatas: Paperback / softback, 200 pages, aukštis x plotis: 279x210 mm, weight: 567 g, XXIII, 200 p., 1 Paperback / softback
  • Serija: Experimental Hematology Today 1987
  • Išleidimo metai: 05-Oct-2011
  • Leidėjas: Springer-Verlag New York Inc.
  • ISBN-10: 1461283396
  • ISBN-13: 9781461283393
Kitos knygos pagal šią temą:
  • Formatas: Paperback / softback, 200 pages, aukštis x plotis: 279x210 mm, weight: 567 g, XXIII, 200 p., 1 Paperback / softback
  • Serija: Experimental Hematology Today 1987
  • Išleidimo metai: 05-Oct-2011
  • Leidėjas: Springer-Verlag New York Inc.
  • ISBN-10: 1461283396
  • ISBN-13: 9781461283393
Kitos knygos pagal šią temą:
Siegmund J. Baum It has become a tradition to commence advocated by Leonard Cole) (3). important meetings of this society with At about the same time, Alpen and reminiscence and nostalgia. Bone marrow Baum (4), using a larger mammal, the dog, transplantation, which has a history of only demonstrated that injecting autologous marrow 30 to 40 years, permits this process, since post irradiation would protect lethally some of the early investigators are still with irradiated animals (see Table). Certainly, us. For example, over the past 15 years, we protection was obtained from the cellular have had three symposia in honor of Egon constituents of the bone marrow. Lorenz. As we all know, the team of Lorenz, We undertook to test on dogs the Uphoff and Congdon was involved in the first hypothesis of Gengozian and Makinodum (5) that successful transplantation of syngeneic and increasing the radiation dose will increase allogeneic bone marrow into irradiated immunologic tolerance for allogeneic implants.

Daugiau informacijos

Springer Book Archives
I. Experimental Bone Marrow Transplantation.- 1 Graft-versus-Host
Disease and Graft-versus-Leukemia in Experimental Systems.- 2 Syngeneic
Graft-versus-Host Disease: Failure of Self: Non-Self Discrimination.- 3
Transfusion-Induced Allosensitization in Marrow Transplant Recipients:
Mechanisms and Preventive Measures.- II. Experimental Bone Marrow
Transplantation.- 4 Utilization of Monoclonal Antibodies for Autologous Bone
Marrow Transplantation.- 5 Characterization of Malignant Lymphoma in Dogs and
Use as a Model for the Development of Treatment Strategies.- 6 Hematopoietic
Cell Transplantation in Murine Globoid Cell Leukodystrophy (The Twitcher
Mouse)A Model of a Human Sphingolipidosis (Krabbe Disease).- 7 Experimental
Basis of Bone Marrow Purging with Chemical and Photodynamic Agents.- III.
Leukemia.- 8 Oncogenes in Acute Myelogenous Leukemia.- 9 Optimal Timing of
Marrow Transplantation for Patients with Acute Nonlymphoblastic and Acute
Lymphoblastic Leukemia.- 10 Perspectives in Treatment of Adult Leukemia with
High Dose Cytoreductive Therapy and Autologous Bone Marrow Treated Ex Vivo.-
IV. Autologous and Allogeneic Marrow Transplants in Leukemia and Lymphoma
(Session A).- 11 Allogeneic and Autologous Marrow Transplants in Acute
Nonlymphoblastic Leukemia (ANLL).- 12 Allogeneic Transplantation for Acute
Lymphoblastic Leukemia.- 13 Autologous Bone Marrow Transplantation in Acute
Lymphoblastic LeukemiaMafosfamide Italian Study Group.- 14 Allogeneic Bone
Marrow Transplantation for Chronic Myeloid Leukemia.- V. Autologous and
Allogeneic Marrow Transplants in Leukemia and Lymphoma (Session B).- 15
Autologous Marrow Transplantation for Hodgkins and Non-Hodgkins Lymphoma:
Preliminary Results Using New Conditioning Regimens.- 16 Long-Term Bone
Marrow Culture inAutologous Transplantation: An In Vitro Biological System
for Purging Leukemic Cells.- 17 Allogeneic Bone Marrow Transplantation for
LeukemiaJapanese Experience.- VI. Aplastic Anemia.- 18 Allogeneic and
Syngeneic Marrow Transplantation for Aplastic Anemia: Overview of Seattle
Results.- 19 Recent Advances and Future Trends in Bone Marrow Transplantation
for Severe Aplastic Anemia.- 20 Allogeneic Bone Marrow Transplantation in
Leukemia.- VII. Acute Graft-versus-Host Disease.- 21 Bone Marrow
Transplantation: The Difficulties Ahead.- 22 Predictive Models of
Graft-versus-Host Disease.- 23 Prevention of Severe GVHD Employing
Cyclosporine in HLA-Matched Marrow Transplant for Leukemia.- VIII. Chronic
Graft-versus-Host Disease.- 24 Chronic Graft-versus-Host Disease:
Pathogenesis, Diagnosis, Treatment and Prognostic Factors.- 25 The Role of
Autoreactive T Lymphocytes in Graft-versus-Host Disease (GVHD).- 26
Predictive Factors for Chronic Graft-versus-Host Disease and Leukemic Relapse
After Allogeneic Bone Marrow Transplantation.- IX. Infections After Bone
Marrow Transplants.- 27 Viral Infection Following Bone Marrow
Transplantation.- 28 Bacterial, Fungal, and Protozoan Infection After Marrow
Transplantation.- 29 Prevention and Treatment of Infections after Bone Marrow
Transplantation.- X. Metabolic and Genetic Disorders.- 30 Bone Marrow
Transplantation for Thalassemia: 156 Cases Transplanted in Pesaro.- 31
Improvement of Clinical Expression of Central Nervous System Manifestation in
Lysosomal Storage Diseases Treated By Bone Marrow Transplantation.- 32 Bone
Marrow Transplantation Following Nuclear Accidents.- Conclusions.